1984
DOI: 10.1016/0165-3806(84)90149-4
|View full text |Cite
|
Sign up to set email alerts
|

Loss of intrinsic striatal neurons after methylazoxymethanol acetate treatment in pregnant rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1987
1987
1998
1998

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…MAM is an alkylating substance that is easily transported through the placenta and methylates the nitrogen in position 7 of the guanine of brain nucleic acids of cells preparing for, or undergoing mitotic division, G1 and M phase of the cell cycle, respectively (Nagata and Matsumoto, 1969;Matsumoto et al, 1972). Previous reports mentioned neuronal depletion of the neocortex (Cattabeni et al, 1989;Johnson and Coyle, 1979;Jones et al, 1982), striatum (Balduini et al, 1984), and hippocampal neuronal ectopia (Sing, 1982) after transplacental exposure to MAM. These studies, however, lack systematic description of the effects of MAM on brain development.…”
Section: Introductionmentioning
confidence: 96%
“…MAM is an alkylating substance that is easily transported through the placenta and methylates the nitrogen in position 7 of the guanine of brain nucleic acids of cells preparing for, or undergoing mitotic division, G1 and M phase of the cell cycle, respectively (Nagata and Matsumoto, 1969;Matsumoto et al, 1972). Previous reports mentioned neuronal depletion of the neocortex (Cattabeni et al, 1989;Johnson and Coyle, 1979;Jones et al, 1982), striatum (Balduini et al, 1984), and hippocampal neuronal ectopia (Sing, 1982) after transplacental exposure to MAM. These studies, however, lack systematic description of the effects of MAM on brain development.…”
Section: Introductionmentioning
confidence: 96%
“…The interest of these, as well as of other data (Beaulieu and Coyle, 1981;Slevin et al, 1982;Balduini et al, 1984), suggests that it may be useful to extend the research to other brain regions and also to increase the number of the neurochemical markers studied as well as of the developmental stages at which the treatment is performed. In the present study, we report data on cholinergic, GABAergic, and excitatory amino acidic neurons in several brain regions of rats treated with MAM at two distinct developmental stages (approximately gestational days 13.5 and 16.5 ((313.5 and G16.5)).…”
Section: Introductionmentioning
confidence: 99%
“…MAM treatment did not appear to affect the binding of a dopamine D 2 antagonist, [ 3 H]spiperone, and a dopamine D 1 antagonist, SCH23390, to D 2 and D 1 receptors, respectively (Beaulieu & Coyle, 1981; Watanabe et al, 1990). However, Balduini, Abbracchio, Lombardelli, and Cattabeni (1984) found that there was a decrease in D 1 -stimulated cyclic adenosine monophosphate production. Thus, MAM treatment appears to result in a relative increase in dopamine activity in the presence of a normal number of D 1 and D 2 receptors available for binding, but the D 1 receptors may be functionally abnormal.…”
Section: Discussionmentioning
confidence: 96%